Fig. 1

(A) Molecular structure of the GCase pharmacological chaperone GT-02216. (B) SPR dose-response for GT-02216 binding to immobilized human GCase protein monitored at acidic (pH 5.0) and neutral (pH 7.4) conditions. (C) SPR binding properties determined at the indicated pH values.